High-dose angiotensin-converting enzyme inhibitor attenuates oxidative stress in patients with chronic kidney disease

Nephrol Dial Transplant. 2009 Feb;24(2):689-90. doi: 10.1093/ndt/gfn665. Epub 2008 Dec 2.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Adult
  • Angiotensin II Type 1 Receptor Blockers / administration & dosage
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage*
  • Benzimidazoles / administration & dosage
  • Benzoates / administration & dosage
  • Cilazapril / administration & dosage
  • Cross-Over Studies
  • Dinoprost / analogs & derivatives
  • Drug Therapy, Combination
  • Female
  • Humans
  • Isoprostanes / urine
  • Male
  • Oxidative Stress / drug effects*
  • Renal Insufficiency, Chronic / drug therapy*
  • Renal Insufficiency, Chronic / metabolism
  • Renin-Angiotensin System / drug effects
  • Telmisartan

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Benzimidazoles
  • Benzoates
  • Isoprostanes
  • Cilazapril
  • 8-epi-prostaglandin F2alpha
  • Dinoprost
  • Telmisartan